Get In Touch

Global Fibrinogen Concentrates Market: Overview

Fibrinogen, also known as coagulation factor I, is a glycoprotein in the blood plasma produced by the liver. It is one of the blood clotting factors that are essential for blood clot formation. Low levels of fibrinogen could lead to thrombosis, blood clot formation inside the blood vessel, interrupting the normal blood flow through the circulatory system. Fibrinogen deficiency is a rare bleeding disorder characterized by mild to severe form of bleeding. The three types for fibrinogen deficiencies are: afibrinogenemia, hypofibrogenemia, and dysfibrinogenemia. Afibrinogenemia is characterized by no fibrinogen in the body. In hypofibrogenemia, fibrinogen is present, but at a lower level than normal. In dysfibrinogenemia, fibrinogen is present, but does not function properly.

Global Fibrinogen Concentrates Market: Key Trends

Rise in demand for fibrinogen concentrates, increase in the number of cases of bleeding disorders, and surge in availability of fibrinogen products are the key factors projected to drive the global fibrinogen concentrates market. In November 2018, Octapharma received marketing authorization form the Swiss Agency for Therapeutic Products for fibryga, a lyophilized fibrinogen concentrate for intravenous infusion indicated for the treatment of congenital and acquired fibrinogen deficiencies. In June 2014, ProMetic Life Sciences, Inc. announced the launch of fibrinogen for commercial sales with successful scale up of the company’s plasma purification center, ProMetic BioProduction, Inc. Furthermore, increase in investment in research and development (R&D) and large number of products under pipeline offer significant opportunities in the market. Biotest AG announced the treatment of first patient in pivotal phase III study in patients with acquired fibrinogen deficiency.

Global Fibrinogen Concentrates Market: Segmentation

The global fibrinogen concentrates market can be segmented based on type, end-user, and region. In terms of type, the market can be divided into human fibrinogen concentrates and animal fibrinogen concentrates. In terms of end-user, the global fibrinogen concentrates market can be categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest market share owing to increase in demand for fibrinogen for various surgical procedures and rise in patient population.

Global Fibrinogen Concentrates Market: Regional Analysis

The global fibrinogen concentrates market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest market share during the forecast period. The market in the region is anticipated to be driven by increase in focus on developing new therapies for rare blooding clotting disorders and improving access to orphan drugs that are indicated for the treatment of rare diseases. The U.S. is expected to account for the largest market share in North America, followed by Canada. Europe is likely to gain market share during the forecast period due to increase in the number of market players offering plasma derived fibrinogen and rise in adoption of new therapies in Germany, France, the U.K., and other countries in the European Union. LFB Group received three European marketing authorizations for FIBCLOT, its human fibrinogen, in Germany, Denmark, and Hungary. The fibrinogen concentrates market in Asia Pacific is projected to be driven by rise in awareness about diagnosis & treatment of fibrinogen deficiencies & other rare diseases and increase in the number of clinical trials for rare diseases. For instance, in March 2012, China Biologics received the Chinese Food and Drug Administration approval to start clinical trials for human fibrinogen indicated for the treatment of fibrinogen deficiency disorders.

Global Fibrinogen Concentrates Market: Competitive Landscape

Key players operating in the global fibrinogen concentrates market are LFB GROUP, Green Cross Corp, Octapharma, ThermoFisher Scientific, Inc., Merck KGaA, Affinity Biologicals, Inc., Cayman Chemical, Molecular Innovations, Inc., CSL Limited, Akron Biotech, Enzo Life Sciences, Inc., and Bovogen Biologicals Pty Ltd.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Fibrinogen Concentrates Market

Pre Book